ORBIMED ADVISORS LLC 13D/13G Filings for

ORBIMED ADVISORS LLC 13D and 13G filings for :

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2024-11-08
7:15 pm
Purchase		2024-11-0113DLomond Therapeutics Holdings Inc.ORBIMED ADVISORS LLC2,677,256
9.800%		2,677,256increase
(New Position)		Filing